CDH17 - Blood Test(Arbele)

N/A

Report date: 2024/08/27 11:13:17

Base Information

Drug NameCDH17 - Blood Test(Arbele)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionCadherin-17 modulators

TargetsCadherin-17

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryHong Kong

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesArbele Corp

China Registration ClassN/A

Active CompaniesArbele Corp

Inactive CompaniesN/A

Active IndicationsColorectal Neoplasms

Inactive IndicationsN/A

ATC CodeN/A